The representative western blots above show results from degradation assays on a test strain with the entirely functional system described in
Figure 1 and a control strain that has a non-functional phosphodegron. We observe that upon treatment with α-factor, the test strain has a significantly fainter band as compared to the untreated lane, whereas the control strain does not. This is consistent with our flow cytometry observations. We also observe that when cells are treated with MG132, a proteasome inhibitor, the alpha-factor triggered degradation in the test strain is prevented, implying that the degradation we observe is indeed due to the proteasome as hypothesized.